JP Morgan Chase
INSM icon

JP Morgan Chase’s Insmed INSM Stock Holding History

JP Morgan Chase’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.7M Buy
455,000
+350,000
+333% +$42.4M ﹤0.01% 1516
2026
Q1 		$16.1M Buy
105,000
+10,800
+11% +$1.66M ﹤0.01% 2270
2025
Q4 		$16.4M Buy
94,200
+45,400
+93% +$8.28M ﹤0.01% 2235
2025
Q3 		$7.03M Buy
+48,800
New +$5.98M ﹤0.01% 3054
2025
Q1 		– Sell
-40,600
Closed -$2.8M – 7516
2024
Q4 		$2.8M Buy
40,600
+3,800
+10% +$274K ﹤0.01% 3891
2024
Q3 		$2.69M Sell
36,800
-145,800
-80% -$10.8M ﹤0.01% 3740
2024
Q2 		$12.2M Buy
182,600
+160,200
+715% +$6.21M ﹤0.01% 2275
2024
Q1 		$608K Buy
+22,400
New +$627K ﹤0.01% 4669
2022
Q4 		– Sell
-40,100
Closed -$864K – 6767
2022
Q3 		$864K Buy
+40,100
New +$961K ﹤0.01% 4111
2022
Q1 		– Sell
-29,800
Closed -$812K – 6796
2021
Q4 		$812K Buy
+29,800
New +$852K ﹤0.01% 4532
2019
Q1 		– Sell
-27,000
Closed -$354K – 5904
2018
Q4 		$354K Buy
+27,000
New +$431K ﹤0.01% 4313
2018
Q2 		– Sell
-40,000
Closed -$901K – 5605
2018
Q1 		$901K Buy
+40,000
New +$1.05M ﹤0.01% 3728
2017
Q4 		– Sell
-70,000
Closed -$2.14M – 5496
2017
Q3 		$2.14M Buy
+70,000
New +$1.33M ﹤0.01% 3111

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's INSM Position: Q2 2026 in Review

JP Morgan Chase reduced its Insmed (INSM) stake by 57% in Q2 2026, selling an estimated $1.66B and leaving 10,428,170 shares worth $1.09B. The position accounts for 0.06% of the portfolio, ranked #256.

JP Morgan Chase first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.04B in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • JP Morgan Chase held 10,428,170 shares of Insmed worth $1.09B as of Q2 2026.
  • JP Morgan Chase sold 13,722,329 Insmed shares in Q2 2026, an estimated $1.66B.
  • Insmed made up 0.06% of JP Morgan Chase's portfolio in Q2 2026, its #256 holding.
  • JP Morgan Chase first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Insmed position peaked at $4.04B in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.